Moderna Therapeutics, a biotech company valued at more than $7 billion, is plotting to raise $500 million in what would be the sector’s largest-ever initial public offering.
The company, based in Cambridge, Mass., filed with the Securities and Exchange Commission on Friday in the first step toward listing its shares on the Nasdaq.
About the Author Reprints
As expected, Moderna stock falls from its IPO price on the first day of trading. https://news.alphastreet.com/moderna-nasdaq-mrna-stock-raises-over-600-million-through-ipo-to-debut-on-friday/
These guys are quacks. Savy, senior executives won’t leave a company with truly innovative products that truly work. They will leave, however, if products are phony and full of hype. I have not seen anything announced by Moderna so far, that indicate therapies that actually work. Invest in these guys at your own peril.